Canada Life
NVO

Canada Life’s Novo Nordisk NVO Stock Holding History

Canada Life’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-137,280
Closed -$3.67M – 2500
2016
Q2 		$3.67M Sell
137,280
-58,200
-30% -$1.6M 0.01% 756
2016
Q1 		$5.29M Sell
195,480
-3,480
-2% -$93.2K 0.02% 576
2015
Q4 		$5.79M Sell
198,960
-3,000
-1% -$83K 0.02% 543
2015
Q3 		$5.45M Sell
201,960
-10,380
-5% -$294K 0.02% 542
2015
Q2 		$5.81M Buy
212,340
+38,340
+22% +$1.08M 0.02% 582
2015
Q1 		$4.63M Buy
+174,000
New +$4.01M 0.02% 641
2013
Q4 		– Sell
-180
Closed -$3K – 2286
2013
Q3 		$3K Sell
180
-290,820
-100% -$4.89M ﹤0.01% 1140
2013
Q2 		$4.51M Buy
+291,000
New +$4.84M 0.03% 342

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Canada Life's NVO Position: Q3 2016 in Review

Canada Life sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 137,280 shares — an estimated $3.67M sold.

Canada Life first reported a position in NVO in Q2 2013 and held it in 8 quarters. The position peaked at $5.81M in Q2 2015. 513 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Canada Life reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Canada Life sold 137,280 Novo Nordisk shares in Q3 2016, an estimated $3.67M.
  • Canada Life first reported a position in Novo Nordisk in Q2 2013 and held it in 8 quarters.
  • Canada Life's Novo Nordisk position peaked at $5.81M in Q2 2015.
  • 513 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Canada Life's 13F filing for Q3 2016, filed 27 Oct 2016.